[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100538277":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":35,"collaborators":7,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":7,"eligibilityCriteria":43,"healthyVolunteers":39,"sex":44,"minAge":45,"maxAge":7,"enrollmentInfo":46,"targetDuration":7,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":53,"overallStatus":55,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Power Life Sciences Inc.","INDUSTRY",null,[9],{"name":10,"affiliation":5,"role":11},"Michael B Gill","STUDY_DIRECTOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","(415) 900-4227","bask@withpower.com",[18],{"facility":19,"status":7,"city":20,"state":21,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Power Life Sciences","San Francisco","California","94107","United States","US",{"type":26,"coordinates":27},"Point",[28,29],-122.41942,37.77493,{"lat":29,"lon":28},[32],{"name":10,"role":14,"phone":33,"phoneExt":7,"email":34},"415-900-4227","https:\u002F\u002Fwww.withpower.com\u002Fcontact-us@withpower.com",{"type":36,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100538277","assessing-patient-engagement-in-keratoconus-clinical-research-100538277",false,"NCT06288737","Assessing Patient Engagement in Keratoconus Clinical Research","Exploring Enrollment and Engagement Trends in Individuals Managing Keratoconus: A Comprehensive Examination of Data on Keratoconus Clinical Trials","Inclusion Criteria:\n\n* Signed Written Informed Consent\n* Aged ≥ 18 years old\n* No prior treatment for keratoconus\n\nExclusion Criteria:\n\n* Participant is actively receiving study therapy in another\n* Inability to provide written informed consent\n* Women of childbearing potential without a negative pregnancy test; or women who are lactating.","ALL","18 Years",{"count":47,"type":48},500,"ESTIMATED","OBSERVATIONAL","This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in keratoconus clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors.\n\nIn essence, this trial aims to deepen understanding of the factors influencing participation in keratoconus clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition.",[52],"Keratoconus",[54],"keratoconus","NOT_YET_RECRUITING","2024-02-23",{"date":58,"type":59},"2024-03-01","ACTUAL",{"date":61,"type":48},"2025-03",{"date":63,"type":48},"2027-03",{"name":5,"class":6},1]